Pharmacological Inhibition of PIP4K2 Potentiates Venetoclax-Induced Apoptosis in Acute Myeloid Leukemia
Keli Lima(Universidade de São Paulo), Eduardo Magalhães Rego(Universidade de São Paulo)
Cited by 6
Related Papers
Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet
|Blood|2019|655
The PIP4K2 inhibitor THZ-P1-2 exhibits antileukemia activity by disruption of mitochondrial homeostasis and autophagy
|Blood Cancer Journal|2022|29
Reversine exhibits antineoplastic activity in JAK2V617F-positive myeloproliferative neoplasms
|Scientific Reports|2019|22